|
|
||||||||
Letters to the Editor |
Department of Clinical Chemistry, Klinisch Chemisch Laboratorium, PO Box 850, 8901 BR Leeuwarden, The Netherlands
To the Editor:
I wish to clarify the statement in our report (1) that the Roche lactate dehydrogenase (LD) method "does not provide reliable results" in heparin plasma. The report showed a problem observed only during primary-tube sampling from heparin-plasma tubes from Becton Dickinson. Serum and EDTA plasma caused no problems, suggesting that the method otherwise performed well.
We became aware of data from another laboratory that used Sarstedt sampling tubes and that showed none of the errors we had reported. From additional experiments (manuscript in preparation), we believe that the previously reported errors might be eliminated by adding a predilution step in the analytical sequence. This predilution step now is included in the IFCC method from Roche.
References
The following articles in journals at HighWire Press have cited this article:
![]() |
G. Dimeski, T. Badrick, R. Flatman, and B. Ormiston Roche IFCC Methods for Lactate Dehydrogenase Tested for Duplicate Errors with Greiner and Becton-Dickinson Lithium-Heparin and Greiner Serum Samples Clin. Chem., December 1, 2004; 50(12): 2391 - 2392. [Full Text] [PDF] |
||||
![]() |
R. R. Miles, R. F. Roberts, A. R. Putnam, and W. L. Roberts Comparison of Serum and Heparinized Plasma Samples for Measurement of Chemistry Analytes Clin. Chem., September 1, 2004; 50(9): 1704 - 1706. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |